Changes in sex-specific incidence of lymphoid neoplasms across the lifespan

Bryan Valcarcel; Sara J Schonfeld; Sarah S Jackson; Graça M Dores; Martha S Linet; Lindsay M Morton

doi:10.3324/haematol.2024.285281

Changes in sex-specific incidence of lymphoid neoplasms across the lifespan

Haematologica. 2024 Oct 1;109(10):3408-3413. doi: 10.3324/haematol.2024.285281.

Authors

Bryan Valcarcel¹, Sara J Schonfeld², Sarah S Jackson³, Graça M Dores⁴, Martha S Linet², Lindsay M Morton²

Affiliations

¹ Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD. [email protected].
² Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD.
³ Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD.
⁴ Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD.

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Adult
Age Factors
Aged
Aged, 80 and over
Child
Child, Preschool
Female
Humans
Incidence
Infant
Infant, Newborn
Longevity
Lymphoma* / diagnosis
Lymphoma* / epidemiology
Male
Middle Aged
Sex Factors
Young Adult

Grants and funding

Funding: This work was supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics of the National Cancer Institute, National Institutes of Health, Bethesda, MD. The opinions and information in this article are those of the authors and do not represent the views and/or policies of the U.S. Food and Drug Administration.